Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now

Cardinal Health Inc. (CAH) is well-poised for growth, given its acquisition-driven strategy, a diversified product portfolio and a robust pharmaceutical segment. However, inflationary pressure remains a concern.Shares of this Zacks Rank #3 (Hold) company have lost 4.4% year to date compared with the industry's 0.3% decline. The S&P 500 Index has increased 3% in the same time frame.CAH, with a market capitalization of $23.48 billion, is a nationwide drug distributor and service provider to pharmacies, health ...